Pathway Capital Management, LP
- SEC CIK
- 0001037353
- Latest filing
- Aug 3, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 13, 2021. Long positions only.
- Positions
- 6
- No 13F data for Q4 2020
- Portfolio value
- $18.0M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RBLXRoblox Corp | Stock | 131,036 | $8.49M | 47.1% | – | – | History |
| QTRXQuanterix Corp | COM | 54,946 | $3.21M | 17.8% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 37,399 | $2.99M | 16.6% | – | – | History |
| VIRVir Biotechnology, Inc. | COM | 47,255 | $2.42M | 13.4% | – | – | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 5,151 | $690.0K | 3.8% | – | – | History |
| RUBYRubius Therapeutics, Inc. | COM | 8,562 | $227.0K | 1.3% | – | – | History |